Charité - Universitätsmedizin Berlin, (coordinator) - (CHARITE)

Web site

The CHARITÉ – UNIVERSITÄTSMEDIZIN BERLIN is one of Europe’s largest University hospitals (about 18,000 employees, >1,000,000 patients/year).

The main clinical research topics of the Charité include regenerative medicine, neurology, cardiovascular diseases, cancer, rare diseases, immune disease, and transplantation. The following institutes are part of PROTO projects: BCRT is an interdisciplinary translational research center for regenerative therapies. It conducts research on the body’s own healing processes and develops new therapies and diagnostics. CMSC is the largest academic trauma and orthopedic center in Germany. As a university institution of maximum care for patients from home and abroad, it covers both the operative and conservative treatment of the entire spectrum of modern orthopaedics and trauma surgery. The JWI explores the interplay between mechanics and biology in bone and muscle. It concentrates on basic and applied research in the fields of orthopaedics and trauma surgery and focuses on translation of new innovative therapies from bench to patients and re-evaluates these in an iterative approach. Research and Innovation are a priority for Charitè. Regarding its fundraising ability, Charité is very active at both the national and the European level and, thanks to its scientific excellence, has gained a considerable experience in international and European research projects. Overall, in Horizon 2020, Charité has been involved in 125 funded projects, and in 7 acted as a coordinator.

Main Contacts

Tobias Winkler Project Coordinator

Tobias Winkler (Charité), Full Professor, Head of the Research Group for Advanced Musculoskeletal Therapies within the Center for Musculoskeletal Surgery, Berlin Institute of Health Center for Regenerative Therapies and Julius Wolff Institute of the Charité Berlin and an expert in orthopedic and trauma surgery.

Tazio Maleitzke
BIH Clinician Scientist, deputy group leader of the Research Group for Advanced Musculoskeletal Therapies, and resident for orthopedic and trauma surgery. Expert in clinical trials addressing musculoskeletal diseases and pre-clinical osteoarthritis and rheumatoid arthritis research. Co-Applicant for current Horizon Europe Funding.
Geissler Sven
Georg Duda
Director of the Julius Wolff Institute and spokesperson of the Berlin Institute of Health Center for Regenerative Therapies. His interest is in employing immune-therapeutic and mechano-therapeutic approaches to enable endogenous repair. Here, his interest is to analyse whether a stratification in stable and instable of early OA patients could increase the therapeutic impact in a clinical phase I/IIa trial setting.
Nicholas Brisson
Clinical Biomechanist and Researcher at the Julius Wolff Institute, BIH at Charité – Universitätsmedizin Berlin and Chief Scientific Coordinator of Berlin Movement Diagnostics (BeMoveD), Charité, is an expert in the study of lower-extremity joint injuries and mechanically induced joint degeneration (osteoarthritis). Co-Applicant for the current Horizon Europe Funding.
Srdan Popovic
Clinical Biomechanist and Chief Operation Coordinator of Berlin Movement Diagnostics (BeMoveD), Charité, is an expert in gait analysis for the treatment of lower-extremity musculoskeletal conditions.
Leonie Krahl
Clinical Biomechanist and Physiotherapist at Berlin Movement Diagnostics (BeMoveD), Charité, is an expert in gait analysis for the treatment of lower-extremity musculoskeletal conditions.
Daniel Ibrahim
BIH group leader of the Research Group Gene Regulation in Cell Differentiation and Disease. He is in expert in gene regulation and solving the genetic mechanisms underlying disease, especially in the background of rare skeletal malformations and dysplasias differentiation research. Co-Applicant for current Horizon Europe Funding.
Stefan Mundlos
Full professor, head of the Institute for Medical and Human Genetics, Charité Berlin and group leader of the research group Development & Disease at the Max Planck Institute for Molecular Genetics. Stefan Mundlos is an expert in genetic diseases with a special focus on congenital malformations and skeletal disease.

PROTO Partners